Pharmaceutics (Jun 2024)

Iron-Reduced Graphene Oxide Core–Shell Micromotors Designed for Magnetic Guidance and Photothermal Therapy under Second Near-Infrared Light

  • Orlando Donoso-González,
  • Ana L. Riveros,
  • José F. Marco,
  • Diego Venegas-Yazigi,
  • Verónica Paredes-García,
  • Camila F. Olguín,
  • Cristina Mayorga-Lobos,
  • Lorena Lobos-González,
  • Felipe Franco-Campos,
  • Joseph Wang,
  • Marcelo J. Kogan,
  • Soledad Bollo,
  • Claudia Yañez,
  • Daniela F. Báez

DOI
https://doi.org/10.3390/pharmaceutics16070856
Journal volume & issue
Vol. 16, no. 7
p. 856

Abstract

Read online

Core–shell micro/nanomotors have garnered significant interest in biomedicine owing to their versatile task-performing capabilities. However, their effectiveness for photothermal therapy (PTT) still faces challenges because of their poor tumor accumulation, lower light-to-heat conversion, and due to the limited penetration of near-infrared (NIR) light. In this study, we present a novel core–shell micromotor that combines magnetic and photothermal properties. It is synthesized via the template-assisted electrodeposition of iron (Fe) and reduced graphene oxide (rGO) on a microtubular pore-shaped membrane. The resulting Fe-rGO micromotor consists of a core of oval-shaped zero-valent iron nanoparticles with large magnetization. At the same time, the outer layer has a uniform reduced graphene oxide (rGO) topography. Combined, these Fe-rGO core–shell micromotors respond to magnetic forces and near-infrared (NIR) light (1064 nm), achieving a remarkable photothermal conversion efficiency of 78% at a concentration of 434 µg mL−1. They can also carry doxorubicin (DOX) and rapidly release it upon NIR irradiation. Additionally, preliminary results regarding the biocompatibility of these micromotors through in vitro tests on a 3D breast cancer model demonstrate low cytotoxicity and strong accumulation. These promising results suggest that such Fe-rGO core–shell micromotors could hold great potential for combined photothermal therapy.

Keywords